Ceesay Abraham 4

What Happened
Ceesay Abraham, a director of Charles River Laboratories International, Inc. (CRL), was granted 1,438 restricted stock units (reported as an acquisition) on 2026-05-08. The award is reported at $177.62 per share, for a total grant value of approximately $255,418. This is a compensation award (code A) rather than a market purchase or sale.

Key Details

• Transaction date and type: 2026-05-08 — Grant/award (Form 4 code A).
• Price/value: $177.62 per share; total value ≈ $255,418.
• Shares owned after transaction: Not specified in the provided filing data.
• Vesting/footnote: Footnote F1 — the unvested RSUs vest upon the earlier of 5/8/2027 or the business day before the company’s next annual meeting of shareholders.
• Timeliness: Report filed 2026-05-11 for a 2026-05-08 transaction (appears to be within the typical two-business-day Form 4 reporting window).

Context
This was a director compensation grant (restricted stock units). RSUs are typically subject to forfeiture until they vest and do not necessarily indicate the insider’s view on the stock. Awards to directors are common as part of governance and retention programs; they differ from open-market purchases, which some investors view as a stronger personal investment signal.